Vascular endothelial growth factor enhances atherosclerotic plaque progression

By F. Celletti, J. Waugh, P. Amabile, A. Brendolan, P. Hilfiker, M. Dake. Nature Medicine, 2001

778 citations recorded by the source corpus.

Subfields: Cancer Research, Immunology and Allergy, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/b6f4651796eb621567fbe54c18c8c989ad49f935

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Seppo Ylä-Herttuala
2. S. Bhardwaj
3. H. Roy

In Molecular Biology

1. A. V. van Oosterom
2. Seppo Ylä-Herttuala
3. A. Hoeben
4. E. D. de Bruijn
5. S. Bhardwaj
6. M. Highley
7. H. Wildiers
8. B. Landuyt

Citations in the corpus

• A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation (2002, background): “ApoE / mice reveal consistent plaque formation with a pathomorphology similar to humans (13, 19, 20).”
• Vascular Endothelial Growth Factor and Angiogenesis (2004, background): “Locally produced VEGF-A mobilizes macrophages and monocytes (Celletti et al., 2001; Zhao et al., 2002).”
• Biology of vascular endothelial growth factors (2006, background): “can initiate and/or accelerate atherosclerosis by influencing monocyte activation, adhesion, migration and enhancing vascular permeability [54].”
• Annexin 1: a new paracrine agent secreted by a novel mechanism (2002, neutral): “It may contribute to increased lipid deposition in atherosclerosis, substrate formation in neointimal hyperplasia (Celletti et al. 2001), and neuropathy and retinopathy in diabetes (Aiello & Wong, 2000).”